naltrexone has been researched along with Ischemia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruehl, S; Burns, JW; Cairl, H; Chont, M; Chung, OY; Gilliam, W; Goodlad, JK; Magid, E; Matsuura, J; Somar, K; Stone, K | 1 |
Arduino, C; Benedetti, F; Blanchard, C; Thoen, W; Vighetti, S | 1 |
Gross, GJ; Huh, J; Liang, BT; Nagase, H | 1 |
Lopez, J; Naujokat, P; Toledo-Pereyra, LH; Walters, W; Xavier, R | 2 |
Faden, AI; Yum, SW | 1 |
de Costa, B; Long, JB; Martinez-Arizala, A; Rice, KC; Rigamonti, DD | 1 |
2 trial(s) available for naltrexone and Ischemia
Article | Year |
---|---|
Hypoalgesia associated with elevated resting blood pressure: evidence for endogenous opioid involvement.
Topics: Adult; Anger; Attention; Blood Pressure; Female; Humans; Hypertension; Ischemia; Linear Models; Male; Maze Learning; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pain; Pain Threshold; Reference Values; Sex Factors | 2010 |
Pain as a reward: changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems.
Topics: Adult; Arm; Attitude to Health; Cannabinoid Receptor Antagonists; Culture; Double-Blind Method; Female; Humans; Ischemia; Male; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pain; Persuasive Communication; Physical Endurance; Piperidines; Pyrazoles; Receptors, Cannabinoid; Reward; Rimonabant; Suggestion; Time Factors; Young Adult | 2013 |
5 other study(ies) available for naltrexone and Ischemia
Article | Year |
---|---|
Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels.
Topics: Adenosine Triphosphate; Alkaloids; Animals; Benzophenanthridines; Benzylidene Compounds; Cells, Cultured; Chick Embryo; Enzyme Inhibitors; Glyburide; Heart; Ischemia; Ischemic Preconditioning, Myocardial; Mitochondria, Heart; Myocardium; Naltrexone; Narcotic Antagonists; Phenanthridines; Potassium Channel Blockers; Protein Kinase C; Quinolines | 2001 |
Role of opioid antagonists in the rat liver ischemia model.
Topics: Animals; Calcium Channel Blockers; Hepatic Artery; Ischemia; Liver; Nalbuphine; Naloxone; Naltrexone; Narcotic Antagonists; Portal Vein; Rats; Rats, Inbred Strains; Verapamil | 1991 |
Protective effect of nalmefene and naloxone on the ischemically damaged small bowel.
Topics: Animals; Intestine, Small; Ischemia; Mesenteric Arteries; Naloxone; Naltrexone; Narcotic Antagonists; Necrosis; Rats; Rats, Inbred Strains; Time Factors | 1991 |
Comparison of the neuroprotective effects of the N-methyl-D-aspartate antagonist MK-801 and the opiate-receptor antagonist nalmefene in experimental spinal cord ischemia.
Topics: Animals; Aspartic Acid; Dibenzocycloheptenes; Dizocilpine Maleate; Humans; Ischemia; Male; N-Methylaspartate; Naltrexone; Narcotic Antagonists; Rabbits; Spinal Cord; Time Factors | 1990 |
Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine.
Topics: Animals; Atrophy; Dynorphins; Hindlimb; Ischemia; Male; Naltrexone; Narcotic Antagonists; Paralysis; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Spinal Cord Diseases | 1989 |